Soleno Therapeutics, Inc. (SLNO)
Market Closed
15 May, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
53. 01
0
0%
After Hours
$
-0 -0% 53. 01
2.76B Market Cap
- P/E Ratio
- Div Yield
4.97M Volume
-2.37 Eps
$ 53.01
Previous Close Investors:
Want to track SLNO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 0.67 | - |
| | | 0.21 | 0.8 |
| | | 0.05 | 0.47 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
SLNO Earnings Reports FAQ
What is the earnings per share (EPS) for SLNO?
The current EPS is -2.37.
What is the company's earnings growth rate?
Soleno Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Soleno Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Soleno Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for SLNO at this time, as Soleno Therapeutics, Inc has no recent EPS data to calculate it.
